(VTR) Ventas - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US92276F1003
VTR: Housing, Medical, Buildings, Facilities, Research, Centers
Ventas, Inc. (NYSE: VTR) stands as a formidable player in the longevity economy, a sector poised for growth due to the aging population. With a diversified portfolio of over 1,350 properties across North America and the UK, Ventas strategically balances senior housing communities with medical buildings and research centers, offering a unique blend of real estate and healthcare services. This dual focus not only diversifies income streams but also positions the company to benefit from evolving healthcare needs and technological advancements.
The companys operational prowess, enhanced by its data-driven platform Ventas OI, underscores its ability to optimize performance and deliver value. Backed by a strong financial foundation and strategic relationships, Ventas is well-equipped to capitalize on demographic trends. As the global population ages, Ventas is strategically positioned to lead in this growing market, offering investors a compelling mix of stability and growth potential.
Additional Sources for VTR Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
VTR Stock Overview
Market Cap in USD | 29,223m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 1998-05-04 |
VTR Stock Ratings
Growth 5y | 72.7% |
Fundamental | 20.0% |
Dividend | 48.8% |
Rel. Strength | 48.9 |
Analysts | 4.2/5 |
Fair Price Momentum | 76.27 USD |
Fair Price DCF | 42.60 USD |
VTR Dividends
Dividend Yield 12m | 2.86% |
Yield on Cost 5y | 7.79% |
Annual Growth 5y | -3.42% |
Payout Consistency | 97.2% |
VTR Growth Ratios
Growth Correlation 3m | 87.4% |
Growth Correlation 12m | 83.1% |
Growth Correlation 5y | 47.9% |
CAGR 5y | 23.92% |
CAGR/Max DD 5y | 0.57 |
Sharpe Ratio 12m | 1.92 |
Alpha | 52.75 |
Beta | 1.401 |
Volatility | 23.26% |
Current Volume | 4211.9k |
Average Volume 20d | 3089.6k |
As of March 31, 2025, the stock is trading at USD 68.76 with a total of 4,211,887 shares traded.
Over the past week, the price has changed by +0.81%, over one month by +0.15%, over three months by +18.43% and over the past year by +64.26%.
Neither. Based on ValueRay Fundamental Analyses, Ventas is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 19.96 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VTR as of March 2025 is 76.27. This means that VTR is currently undervalued and has a potential upside of +10.92% (Margin of Safety).
Ventas has received a consensus analysts rating of 4.20. Therefor, it is recommend to buy VTR.
- Strong Buy: 10
- Buy: 4
- Hold: 6
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, VTR Ventas will be worth about 84.2 in March 2026. The stock is currently trading at 68.76. This means that the stock has a potential upside of +22.4%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 75.4 | 9.7% |
Analysts Target Price | 71.3 | 3.6% |
ValueRay Target Price | 84.2 | 22.4% |